Dr. Praveen Kumar Gundelly, MD

Dr. Gundelly practices at University Hospitals Cleveland Medical Center in Cleveland, Ohio, part of University Hospitals Health System.

Dr. Gundelly's NPI, 1700033313, was assigned on August 26, 2008. Dr. Gundelly holds Ohio license 35.090885.

Dr. Gundelly's primary practice is University Hospitals Cleveland Medical Center, at 11100 Euclid Avenue, Cleveland, OH 44106 in Cuyahoga County. The practice phone is (216) 844-1000.

Dr. Gundelly's primary practice is University Hospitals Cleveland Medical Center in Cleveland, Ohio, part of University Hospitals Health System. The medical group on file is University Hospitals Medical Practices. Dmand AI also links Dr. Gundelly to 1 more home health agency, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gundelly practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Gundelly's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dmand AI has Dr. Gundelly's licenses on file in 3 states: Ohio, Iowa and Kentucky.

CMS data shows 245 Medicare services from Dr. Gundelly across 6 procedure codes in 2024, for 121 Medicare patients. Medicare paid $20,289 for them.

CMS counts 121 Medicare patients who saw Dr. Gundelly in 2024. The largest group is 65 to 74, with 61 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 3.99, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gundelly's median patient age at 66, with 40% women.

In 2024, Dr. Gundelly wrote 414 Medicare Part D claims for 76 patients. 83% of them were for generic drugs. CMS names the drug for 320 of them, across 15 drugs with 11 or more claims each, at $35,423 in total drug cost. In 2023, CMS named 329 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Gundelly for performance year 2024, reported as part of a group. Dr. Gundelly accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gundelly as offering telehealth.

Dmand AI links 6 papers to Dr. Gundelly, published from 2016 to 2022. The most frequent topics are Actinomycetales Infections, COVID-19 and Rhodococcus equi. Dr. Gundelly's most frequent co-authors are Alice Chaffin Thornton, MD, Hesham Ahmed Abboud, MD and Robin Arthur Buerki, MD.

CMS Open Payments shows 163 general payments to Dr. Gundelly from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Gilead Sciences, Inc. paid the most, $631.